ADA The Pathway to Stop Diabetes Accelerator Award

The Pathway to Stop Diabetes® program intends to attract brilliant scientists approaching the peak of their careers in diabetes research, and to accelerate their research progress by providing the necessary resources and support for conducting transformative science.

 

This call for nominations will prioritize exceptional investigators across the spectrum of diabetes research, spanning basic science through public health research and implementation science. The ideal applicant will propose innovative research with the ultimate goal of improving the lives of people at risk of diabetes or living with the disease - and the pathway to this impact is clear.

 

Nominations are welcomed from all areas of diabetes and span prevention, management, and cure of all diabetes types (i.e. type 1, type 2 and gestational), diabetes-related disease states (obesity, prediabetes, and other insulin resistant states) and complications. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics, and physics.

 

Accelerator award is intended to provide flexible, long-term salary and research support to early career researchers who are proposing innovative and ambitious diabetes-related research programs, and who have distinguished themselves as exceptionally talented and promising research investigators.

$325,000 per year (including 30% indirect costs) for up to five years.

·       Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree. 

·       Applicants must hold independent faculty positions and have demonstrated independent productivity in diabetes research. 

·       Applicants may currently hold independent NIH funding (K or R awards,including an initial NIH R01) but must not have applied for, or received, an NIH R01 renewal or a second R01 award.

·       Must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. 

·       If funded, the Principal Investigator must agree to devote at least 75% of their total time and overall effort towards research. This percentage includes time dedicated to the Association-funded grant in addition to grants supported by other funding agencies. Please note that during the award’s duration, the Principal Investigator must commit between 25-50% effort towards the Association funded project.

For more information on this funding opportunity, please refer to the Pathway to Stop Diabetes: Call for Nominations document.

 

Two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research. 

Internal Proposal Due: June 2, 2025 (by 11:59 pm)

Sponsor applications Due: July 23, 2025

INTERNAL PROPOSAL FORMAT
Proposals should be prepared with at least 1-inch margins, 11-point font size, and are required to contain the following components:

1.       Cover page with a descriptive title, your name, departmental affiliation(s), and Program Track ( basic through preclinical research or clinical through public health research). 

2.       Essay questions (0.5-page limit) Very briefly provide answers to each of the following questions:
What makes your research strategy particularly innovative and important for people with diabetes? 
What makes it uniquely suited for this program rather than a traditional research grant program?

3.       Project Description (2-page limit including figures; references may be listed on a separate page) 
a) Scientific question(s)/specific problem(s) to be addressed.
b) Specific approach(es) that will be employed.
c) Significance and potential impact of the work.
d) The potential risks and challenges, and how they will be overcome

4.       Biosketch (5-page limit)

CONTACT AND ADDITIONAL INFORMATION
For questions about the limited submission process, please contact: Katya Klyachko, Director, Research Development

For questions regarding the foundation or eligibility, please contact: Michelle Melin-Rogovin, Senior Director, Foundation Relations

 

 

 

 

Apply Now